Fermentación controlada de aceitunas verdes picholine marroquíes sometidas a choque térmico e inoculadas sin sal

The present work reports the controlled fermentation of heat-shocked, unsalted and inoculated green olives. The effects of heat-shock (60, 70 and 80 °C three times for 5 min), inoculation with the oleuropeinolytic strain of L. plantarum FSO175 (L.p-FSO175) and the addition of Cell-Free Supernatant of C. pelliculosa L18 (CFS of C.p-L18) on the fermentation process of unsalted green olives were examined. The results showed a drastic reduction in the initial indigenous Enterobacteria, and an improvement in the acidification of heat-shocked olives at 70 and 80 °C, when compared to 60 °C. The inoculation with L.p-FSO175 and addition of CFS of C.p-L18 enhanced the fermentation and preservation of unsalted green olives, indicated by a significant decrease in pH, increase in free acidity and total disappearance of Enterobacteria. The heat-shock treatment at high temperature (80 °C), inoculation with L.p-FSO175 and addition of CFS of C.p-L18 led to the best reduction in bitterness, and favorable color changes (L, a, and b) in fermented olives. This sequential method led to more appreciated sensory characteristics (mainly bitterness and color) of fermented olives, lower spoilage incidence in olives, and reduced fermentation time to 50 days, and therefore may be suitable to control the fermentation of unsalted green olives of the Moroccan picholine variety.El presente trabajo reporta la fermentación controlada de aceitunas verdes sometidas a choque térmico, sin salar e inoculadas. Se estudian los efectos del choque térmico (60 °C, 70 °C y 80 °C tres veces durante 5 min), la inoculación con cepa oleuropeinolítica de L. plantarum FSO175 (L.p-FSO175) y la adición de sobrenadante libre de células de C. pelliculosa L18 (CFS de C.p-L18), sobre el proceso de fermentación de aceitunas verdes sin salar. Los resultados mostraron la drástica reducción de las enterobacterias autóctonas iniciales, y la mejora de la acidificación de las aceitunas sometidas a choque térmico de 70 °C y 80 °C, en comparación con 60 °C. La inoculación con L.p-FSO175 y la adición de CFS de C.p-L18 mejoró la fermentación y conservación de las aceitunas verdes sin salar, indicada por una disminución significativa del pH, aumento de la acidez libre y desaparición total de enterobacterias. El choque térmico a alta temperatura (80 °C), la inoculación con L.p-FSO175 y la adición de CFS de C.p-L18 condujeron a una mejor reducción del amargor y cambios de color favorables (L, a y b) en aceitunas fermentadas. Este método secuencial, que permitió apreciar las características sensoriales (principalmente amargor y color) de las aceitunas fermentadas, y una menor incidencia de deterioro en las aceitunas, y redujo el tiempo de fermentación a 50 días, puede ser adecuado para controlar la fermentación de aceitunas verdes sin salar de Marruecos, variedad picholine

Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro

Overall health spending across OECD countries accounted for 9.3% of GDP on average in 2012 (OECD Health Statistics 2014). Policymakers are keen to ensure that this money is spent wisely and that healthcare organisations are effi cient, effective and equitable in delivering healthcare services and interventions. They are spurred on by the fact that citizens are also concerned about the cost, quality and accessibility of healthcare. Opinion polls in the UK consistently show that healthcare is one of the three most important issues in deciding which political party the public will vote for (Ipsos MORI 2014). But how can policymakers, health service managers and healthcare practitioners ensure that healthcare funds are spent wisely? One response is that they should pay more attention to what we know as a result of healthcare research. There is widespread recognition that research has the potential to inform and guide the improvement of healthcare services, but there is frustration that this potential is often not fulfi lled (Cooksey 2006; CERAG 2008). A gulf continues to exist between what researchers know (the state of the science) and what practitioners do (the state of the art) (Rycroft-Malone et al. 2013). As a result, the quality, cost and patient experience of healthcare continue to be compromised (Davis 2006)

Biomonitoring of occupational exposure to phthalates: A systematic review

Introduction: Phthalates, a group of ubiquitous industrial chemicals, have been widely used in occupational settings, mainly as plasticizers in a variety of applications. Occupational exposure to different phthalates has been studied in several occupational settings using human biomonitoring (HBM). Aim: To provide a comprehensive review of the available literature on occupational exposure to phthalates assessed using HBM and to determine future data needs on the topic as part of the HBM4EU project. Methods: A systematic search was carried out in the databases of Pubmed, Scopus, and Web of Science for articles published between 2000 and September 4, 2019 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 22 studies on the occupational HBM of phthalates was considered suitable for review. Results and discussion: Among the reviewed studies, 19 (86%) focused on DEHP, an old phthalate that is now subject to authorization and planned to be restricted in the EU. Concentrations of MEHHP, one of its metabolites, varied up to 13-fold between studies and across sectors when comparing extreme geometric means, ranging from 11.6 (similar to the general populations) to 151 μg/g creatinine. Only 2 studies focused on newer phthalates such as DiNP and DPHP. Concerning the geographical distribution, 10 studies were performed in Europe (including 6 in Slovakia), 8 in Asia, and 4 in North America, but this distribution is not a good reflection of phthalate production and usage levels worldwide. Most HBM studies were performed in the context of PVC product manufacturing. Future studies should focus on: i) a more uniform approach to sampling timing to facilitate comparisons between studies; ii) newer phthalates; and iii) old phthalates in waste management or recycling. Conclusion: Our findings highlight the lack of recent occupational HBM studies on both old and new phthalate exposure in European countries and the need for a harmonized approach. Considering the important policy actions taken in Europe regarding phthalates, it seems relevant to evaluate the impact of these actions on exposure levels and health risks for workers

Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (cefuzime and zinnat) in healthy human volunteers

A bioequivalence study of two oral formulations of 500 mg cefuroxime axetil was carried out in 24 healthy volunteers following a single dose, standard two-treatment cross-over design at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, working jointly with King Khalid University Hospital. The two formulations used were Cefuzime (Julphar, United Arab Emirates) as the test and Zinnat (Glaxo Wellcome, England) as the reference product. Both test and reference tablets were administered to each subject after an overnight fasting on two treatment days separated by a 1-week washout period. After dosing, serial blood samples were collected for a period of 8 h. Plasma harvested from blood was analysed for cefuroxime by a sensitive, reproducible and accurate high pressure liquid chromatography (HPLC) method. Various pharmacokinetic parameters including AUC0 t, AUC0 8, Cmax, Tmax, T1:2 and Kel were determined from plasma concentrations of both formulations and found to be in good agreement with reported values. AUC0 t, AUC0 8 and Cmax were tested for bioequivalence after log-transformation of data. No significant difference was found based on an analysis of variance (ANOVA); 90% confidence interval for test:reference ratio of these parameters were found within bioequivalence acceptance range of 80–125%. Based on these statistical inferences, it was concluded that Cefuzime is bioequivalent to Zinnat